Acute methotrexate neurotoxicity: Findings on diffusion-weighted imaging and correlation with clinical outcome

American Journal of Neuroradiology

Volumn 25, Issue 10, 2004, Pages 1688-1695

  Rollins, Nancy ^a,b   Winick, Naomi ^a   Bash, Robert ^a   Booth, Timothy ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b CHILDREN S MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GADOLINIUM; METHOTREXATE; ANTINEOPLASTIC ANTIMETABOLITE;

ACUTE LYMPHOCYTIC LEUKEMIA; ADOLESCENT; ARTICLE; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CORPUS CALLOSUM; CORRELATION ANALYSIS; DIAGNOSTIC IMAGING; DIFFUSION; DIFFUSION WEIGHTED IMAGING; DISEASE ASSOCIATION; FACE MALFORMATION; HEMIPARESIS; HUMAN; MEDICAL RECORD REVIEW; MOTOR DYSFUNCTION; NEUROTOXICITY; NUCLEAR MAGNETIC RESONANCE; SENSORY DYSFUNCTION; SYMPTOMATOLOGY; TREATMENT OUTCOME; WEAKNESS; ACUTE DISEASE; ARM; ATAXIC APHASIA; BRAIN; CEREBROVASCULAR ACCIDENT; CEREBROVASCULAR DISEASE; CHEMICALLY INDUCED DISORDER; CHILD; DYSKINESIA; FACIAL NERVE PARALYSIS; FEMALE; HEMIPLEGIA; MALE; MUSCLE WEAKNESS; PATHOLOGY; TOXICITY AND INTOXICATION;

ACUTE DISEASE; ADOLESCENT; ANTIMETABOLITES, ANTINEOPLASTIC; APHASIA, BROCA; ARM; BRAIN; CEREBROVASCULAR ACCIDENT; CEREBROVASCULAR DISORDERS; CHILD; DIFFUSION MAGNETIC RESONANCE IMAGING; DYSKINESIA, DRUG-INDUCED; FACIAL PARALYSIS; FEMALE; HEMIPLEGIA; HUMANS; LEUKEMIA, LYMPHOCYTIC, ACUTE; MALE; METHOTREXATE; MUSCLE WEAKNESS; NEUROTOXICITY SYNDROMES; SENSATION DISORDERS;

EID: 16644398327     PISSN: 01956108     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Winick NJ, Bowman WP, Kamen BA, et al. Unexpected acute neurologic toxicity in the treatment of children with acute lymphoblastic leukemia. J Natl Cancer Inst 1992;84:252-256
2. Mahoney DH, Shuster JJ, Nitschke R, et al. Acute neurotoxicity in children with B-precursor acute lymphoid leukemia: an association between intermediate-dose intravenous methotrexate and intrathecal triple therapy: a Pediatric Oncology Group study. J Clin Oncol 1998;16:1712-1722
3. Winick N, Shuster JJ, Bowman WP, et al. Intensive oral methotrexate protects against lymphoid marrow relapse in childhood H-precursor acute lymphoblastic leukemia. J Clin Oncol 1996;14:2803-2811
4. Rubnitz JE, Relling MV, Harrison, et al. Transient leukoencephalopathy following high dose methotrexate treatment in childhood acute lymphocytic leukemia. Leukemia 1998;12:1176-1181
5. Rubinstein LJ, Herman MM, Long TF, Wilbur JR. Disseminated necrotizing leukoencephalopathy: a complication of treated central nervous system leukemia and lymphoma. Cancer 1975;35:291-305
6. Ebner F, Ranner G, Slave I, et al. MR findings in methotrexate-induced CNS abnormalities. AJNR Am J Neuroradiol 1989;10:959-964
7. Davidson A, Payne G, Leach MO, et al. Proton magnetic resonance spectroscopy of the brain following high-dose methotrexate therapy for childhood cancer. Med Pediatr Oncol 2000;35:28-34
8. Komatsu K, Takada G, Uemura K, Shisido F, Kanno I. Decrease in cerebral metabolic rate of glucose after high dose methotrexate in childhood acute lymphocytic leukemia. Pediatric Neurol 1990;6:303-306
9. Kishi S, Greiner J, Cheng C, et al. Homocystcine, pharmacokinetics, and neurotoxicity in children with leukemia. J Clin Oncol 2003;15:3084-3091
10. Mizuasawa S, Kondoh Y, Murakami M, et al. Effect of methotrexate on local cerebral blood flow in conscious rats. Jpn J Pharmacol 1988;48:499-501
11. Harila-Saari AH, Ahonen AKA, Vainionpaa LK, et al. Brain perfusion after treatment of childhood acute lymphoblastic leukemia. J Nucl Med 1977;38:82-88
12. Provenzale JM, Jahan R, Naidich TP, Fox AJ. Assessment of the patient with hyperacute stroke: imaging and therapy. Radiology 2003;229:347-359
13. Provenzale JM, Sorensen AG. Diffusion-weighted MR imaging in acute stroke: theoretical considerations and clinical applications. AJR Am J Roentgenol 1999;173:1459-1468
14. Rovira A, Rovira-Gols A, Pedraza S, et al. Diffusion-weighted imaging in the acute phase of transient ischemic attacks. AJNR Am J Neuroradiol 2002;23:77-83
15. Yaffe K, Ferreiro D, Barkovich JA, Rowley H. Reversible MRI abnormalities following seizures. Neurology 1995;45:104-107
16. Paako E, Harila-Saari AH, Vainionpaa LK, Himanen S, Pyhtinen J, Lanning M. White matter changes on MR during treatment in children with acute lymphoblastic leukemia: correlation with neuropsychological findings. Med Pediatr Oncol 2000;35:456-461
17. Paako E, Vainionpaa LK, Pyhtinen J, Lanning M. Minor changes on cranial MRI during treatment in children with acute lymphocytic leukemia. Neuroradiology 1996;38:264-268
18. Chen C-Y, Zimmerman RA, Faro S, Bilaniuk LT, Chou TY, Malloy PT. Childhood leukemia: central nervous system abnormalities during and after treatment. AJNR Am J Neuroradiol 1996;17:295-310
19. Sandoval C, Kutscher M, Jayabose S, Tenner M. Neurotoxicity of intrathecal methotrexate: MR imaging findings. AJNR Am J Neuroradiol 2003;24:1887-1890
20. Kirshner HS. Language disorders. In: Bradley WG, Daroff RB, Fenichel GM, Marsden CD, eds. Neurology in Clinical Practice. 2nd ed. Boston: Butterworth-Heinemann; 1996:140-141
21. Shin RK, Stern JW, Janss AJ, et al. Reversible posterior leukoencephalopathy during the treatment of acute lymphoblastic leukemia. Neurology 2001;56:388-391